Last reviewed · How we verify
NCT05997745: PAG/NUTRI
Enteral Nutrition in Acute Generalized Peritonitis
NA trial testing study group in Enteral and Supplement Feeds Adverse Reaction in 76 participants. Status unknown.
30 October 2023
Quick facts
| Lead sponsor | Université Evangélique enAfrique |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 76 |
| Start date | 20 August 2023 |
| Primary completion | 30 October 2023 |
| Estimated completion | 30 October 2023 |
Drugs / interventions tested
- study group — full drug profile →
Conditions studied
- Enteral and Supplement Feeds Adverse Reaction — all drugs for Enteral and Supplement Feeds Adverse Reaction →
- Peritonitis; Acute — all drugs for Peritonitis; Acute →
Sponsor
Université Evangélique enAfrique
Who can join
2 and older, any sex, with Enteral and Supplement Feeds Adverse Reaction or Peritonitis; Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hospitals in South Kivu always have problems supplying artificial enteral nutritional products because of their high cost and low availability in our areas. While the Province has cereals, knowing their nutritional composition would enable the formulation of a nutritional product based on local protein-energy products. Hence the questions below: Can a local cereal-based protein-energy ration be used instead of a costly imported artificial nutritional solution to improve the nutritional status of patients operated on for PAG? What is the tolerance of this early enteral nutrition on the healing and functional recovery of patients compared with an artificial nutritional solution? To answer these questions, a randomized clinical trial has been designed with the following objectives: * To formulate an enteral diet using cereals available in our environment with a protein-calorie composition superimposable on the artificial enteral ration, * Evaluate the tolerance and advantages of early enteral nutrition with a locally manufactured protein-caloric ration vs. a commercially available artificial nutritional solution in patients undergoing surgery for PAG.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05997745
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of study group
Trials testing the same drug.
- NCT06080217 — RF in the Treatment OAB in UUI- a Prospective Randomized Placebo Controlled Study · NA · unknown
- NCT05894733 — The Effects of Frequent Follow up on Compliance in Patients Receiving PAP Therapy Due to OSA (Pap: Positive Airway Press · NA · completed
- NCT03663426 — Impact of Opioid Free Anesthesia on Outcome After Hip Arthroplasty by Direct Anterior Approach. · NA · completed
- NCT03618433 — KİNECT® - Video Games Based Physiotherapy Programme in Patients With Breast Cancer Surgery · NA · completed
- NCT03851224 — Immediate Implant With no Graft , Autogenous Graft or Xenograft. · NA · unknown
Other Université Evangélique enAfrique trials
Trials by the same sponsor.
- NCT05979701 — Simulation for the Retention of Skills in the Management of Obstetric Hemorrhages · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05997745 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Université Evangélique enAfrique
- Last refreshed: 18 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05997745.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing